ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00212836
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : May 2, 2017
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.